William Aliski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William Aliski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William Aliski. William Aliski is Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in X4 Pharmaceuticals, Inc ($ASNS) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).
Latest Insider Trading Transactions of William Aliski
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGTC, RARE, ASNS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | ASNS | X4 Pharmaceuticals ... | Aliski William | Director | Option Exercise | A | 9.50 | 6,000 | 57,000 | 6,000 | |
Feb 23 2021 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 97.85 | 7,500 | 733,875 | 0 | |
Feb 23 2021 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Gift | G | 0.00 | 1,000 | 0 | 64,704 | 65.7 K to 64.7 K (-1.52 %) |
Feb 23 2021 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 149.01 | 7,500 | 1,117,575 | 65,704 | 73.2 K to 65.7 K (-10.25 %) |
Feb 23 2021 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 97.85 | 7,500 | 733,875 | 73,204 | 65.7 K to 73.2 K (+11.41 %) |
Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 58.74 | 5,000 | 293,700 | 0 | |
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 86.57 | 5,000 | 432,850 | 57,018 | 62 K to 57 K (-8.06 %) |
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 58.74 | 5,000 | 293,700 | 62,018 | 57 K to 62 K (+8.77 %) |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 2,550 | 0 | 57,018 | 54.5 K to 57 K (+4.68 %) |
Jun 11 2020 | ASNS | X4 Pharmaceuticals ... | Aliski William | Director | Option Exercise | A | 8.69 | 3,427 | 29,781 | 3,427 | |
Jun 03 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 74.02 | 20,000 | 1,480,322 | 70,350 | 90.4 K to 70.4 K (-22.14 %) |
May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 40.37 | 7,500 | 302,775 | 0 | |
May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 74.65 | 7,500 | 559,875 | 47,924 | 55.4 K to 47.9 K (-13.53 %) |
May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 40.37 | 7,500 | 302,775 | 55,424 | 47.9 K to 55.4 K (+15.65 %) |
Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
Sep 20 2019 | ASNS | X4 Pharmaceuticals ... | Aliski William | Director | Option Exercise | A | 14.04 | 6,854 | 96,230 | 6,854 | |
Sep 20 2019 | ASNS | X4 Pharmaceuticals ... | Aliski William | Director | Option Exercise | A | 14.04 | 6,854 | 96,230 | 6,854 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 3,000 | 0 | 47,924 | 44.9 K to 47.9 K (+6.68 %) |
Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.24 | 500 | 1,620 | 8,500 | 8 K to 8.5 K (+6.25 %) |
Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.25 | 4,300 | 13,975 | 8,000 | 3.7 K to 8 K (+116.22 %) |
Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.24 | 1,200 | 3,882 | 3,700 | 2.5 K to 3.7 K (+48.00 %) |
Dec 07 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 49.69 | 6,000 | 298,140 | 90,350 | 96.4 K to 90.4 K (-6.23 %) |
Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
Nov 08 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 55.67 | 6,000 | 334,020 | 96,350 | 102.4 K to 96.4 K (-5.86 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | C | 0.00 | 266,343 | 0 | 0 | |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 73.38 | 6,000 | 440,280 | 102,350 | 108.4 K to 102.4 K (-5.54 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 53.97 | 650 | 35,081 | 108,350 | 109 K to 108.4 K (-0.60 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 122.58 | 400 | 49,032 | 109,000 | 109.4 K to 109 K (-0.37 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 85.94 | 2,000 | 171,880 | 109,400 | 111.4 K to 109.4 K (-1.80 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 68.65 | 10,500 | 720,825 | 111,400 | 121.9 K to 111.4 K (-8.61 %) |
Oct 09 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | C | 0.00 | 84,970 | 0 | 121,900 | 36.9 K to 121.9 K (+230.08 %) |
Sep 24 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 4.40 | 25,000 | 110,000 | 25,000 | |
Aug 08 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 76.66 | 3,750 | 287,475 | 72,610 | 76.4 K to 72.6 K (-4.91 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 3,000 | 0 | 76,360 | 73.4 K to 76.4 K (+4.09 %) |
Jan 25 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 21.00 | 11,500 | 241,500 | 0 | |
Jan 25 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 21.00 | 11,500 | 241,500 | 73,360 | 61.9 K to 73.4 K (+18.59 %) |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 1,875 | 0 | 61,860 | 60 K to 61.9 K (+3.13 %) |
Dec 05 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Option Exercise | M | 21.00 | 6,000 | 126,000 | 11,500 | ||
Dec 05 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Sell | S | 78.70 | 2,000 | 157,400 | 59,985 | 62 K to 60 K (-3.23 %) | |
Dec 05 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Sell | S | 77.94 | 4,000 | 311,760 | 61,985 | 66 K to 62 K (-6.06 %) | |
Dec 05 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Buy | M | 21.00 | 6,000 | 126,000 | 65,985 | 60 K to 66 K (+10.00 %) | |
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Aliski William | Grant | A | 0.00 | 1,875 | 0 | 59,985 | 58.1 K to 60 K (+3.23 %) | |
Jun 22 2015 | RARE | Ultragenyx Pharmac ... | Aliski William | Option Exercise | A | 97.85 | 7,500 | 733,875 | 7,500 | ||
Dec 08 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 42.46 | 3,109 | 132,013 | 60,010 | 63.1 K to 60 K (-4.93 %) |
Dec 08 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 41.83 | 2,891 | 120,929 | 63,119 | 66 K to 63.1 K (-4.38 %) |
Oct 22 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 3.01 | 29,108 | 87,615 | 0 | |
Oct 22 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 3.01 | 29,108 | 87,615 | 66,010 | 36.9 K to 66 K (+78.88 %) |
Jul 17 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 40.37 | 7,500 | 302,775 | 7,500 | |
Feb 07 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | J | 3.01 | 29,108 | 87,615 | 0 | |
Feb 07 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | J | 0.96 | 91,241 | 87,500 | 0 | |
Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 21.00 | 17,500 | 367,500 | 17,500 | |
Feb 03 2014 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | P | 21.00 | 5,000 | 105,000 | 36,903 | 31.9 K to 36.9 K (+15.67 %) |
Page: 1